Tela Bio Inc (TELA) — Cash Flow-to-Debt Ratio
Tela Bio Inc (TELA) has a Cash Flow-to-Debt Ratio of -0.06x as of December 2025, meaning its operating cash flow of $-4.87 Million could theoretically repay 0% of its total liabilities ($75.11 Million) in one year. See working capital position of Tela Bio Inc to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tela Bio Inc Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Tela Bio Inc across 9 annual periods. Also explore TELA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tela Bio Inc (2017–2025)
Year-by-year debt coverage analysis for Tela Bio Inc. For market capitalisation and broader financial context, see market value of Tela Bio Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.38x | $-28.22 Million | $75.11 Million | ▲ +46.8% |
| 2024 | -0.71x | $-41.59 Million | $58.87 Million | ▼ -2.3% |
| 2023 | -0.69x | $-40.86 Million | $59.17 Million | ▲ +9.3% |
| 2022 | -0.76x | $-40.75 Million | $53.55 Million | ▼ -6.1% |
| 2021 | -0.72x | $-30.43 Million | $42.45 Million | ▼ -9.7% |
| 2020 | -0.65x | $-24.46 Million | $37.43 Million | ▲ +5.4% |
| 2019 | -0.69x | $-25.52 Million | $36.96 Million | ▼ -472.2% |
| 2018 | -0.12x | $-19.92 Million | $165.09 Million | ▲ +8.8% |
| 2017 | -0.13x | $-16.37 Million | $123.70 Million | — |